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Abstract
HIV-1 is present in anatomical compartments and bodily fluids. Most transmissions occur through sexual acts, making virus
in semen the proximal source in male donors. We find three distinct relationships in comparing viral RNA populations
between blood and semen in men with chronic HIV-1 infection, and we propose that the viral populations in semen arise by
multiple mechanisms including: direct import of virus, oligoclonal amplification within the seminal tract, or
compartmentalization. In addition, we find significant enrichment of six out of nineteen cytokines and chemokines in
semen of both HIV-infected and uninfected men, and another seven further enriched in infected individuals. The
enrichment of cytokines involved in innate immunity in the seminal tract, complemented with chemokines in infected men,
creates an environment conducive to T cell activation and viral replication. These studies define different relationships
between virus in blood and semen that can significantly alter the composition of the viral population at the source that is
most proximal to the transmitted virus.
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Introduction
Sexual transmission of the human immunodeficiency virus type 1
(HIV-1) is the most common mode of transmission worldwide.
Duringsexualtransmission,genitalsecretionsarethe most proximal
source of the transmitted virus. Thus, an understanding of the virus
at these sites is central to understanding the transmission event and
the nature of the transmitted virus. In this study we have explored
the nature of viral populations in seminal plasma.
Virus enters the male genital tract during primary infection
[1–5]. Initially, the virus found in the semen is similar, if not
identical, to that found in the blood [6,7]. During primary
infection the viral RNA load is elevated in both the blood and the
semen [1,3]. The probability of transmission is related to the level
of virus in the blood of the donor [8–11] and, based on a small
cohort, to the level of virus in the semen [12]. Factors that induce
inflammation in the seminal tract, such as sexually transmitted
infections (STI), can raise the level of virus in semen [13], and this
may contribute to the transmission of HIV-1 by the sexual route
[14]. In addition, the endogenous semen-derived enhancer of virus
infection (SEVI), a fragment of prostatic acid phosphatase, has
been shown to increase infectious viral titers in vitro by several
orders of magnitude [15].
The presence of virus in semen raises the possibility that virus
found in semen could be the product of replication within the
seminal tract. CD4+ T cells are found in semen indicating the
presence of target cells that could support replication [16,17]. SIV-
infected macaques have infected cells within the tissues of the
seminal tract [18,19], supporting the possibility for local viral
replication. Several studies have examined the relationship
between viral populations found in blood and semen and noted
differences (i.e. compartmentalization) using discordant drug
resistance markers [20–24], differences in population markers
[25,26], or phylogenetic analysis [27–32].
In this study we have carried outad e t a i l e de x amination of
the viral populations in semen, comparing the env gene in blood
plasma and seminal plasma. The men were therapy-naive and
chronically infected with subtype C (n=12) or subtype B (n=4)
HIV-1. We found a varied and complex relationship between
these two compartments which suggests multiple types of
PLoS Pathogens | www.plospathogens.org 1 August 2010 | Volume 6 | Issue 8 | e1001053b i o l o g i c a lp h e n o m e n a .T h e r ei se v i d e n c ef o rt h ed i r e c ti m p o r t
of virus from the blood to the semen, evidence for clonal
amplification of a subset of genotypes within the seminal tract,
a n de v i d e n c ef o rs u s t a i n e dr e p l i c a t i o na n dd i s t i n c te v o l u t i o no f
virus within the seminal tract resulting in compartmentalization.
The latter two of these phenomena result in seminal plasma
viral populations that are distinct from those found in the blood,
and thus distinct at the site proximal to transmission.
Furthermore, semen is enriched in cytokines which may
increase the potential for independent viral replication within
the seminal tract.
Results
Cohort characteristics and generation of sequences
In this study, we examined viral populations and cytokine/
chemokine relationships in paired blood and semen samples
collected from men with chronic HIV-1 infection in Lilongwe,
Malawi (n=12) [33], or from the CHAVI 001 clinical study
(n=4). We utilized a cohort of men without urethritis to minimize
any potential confounders on viral loads, viral populations, or
cytokine profiles. The clinical parameters of their HIV-1 infection
are shown in Table 1. There was no evidence of urethritis in the
dermatology clinic subjects, although the diagnosed cases of
syphilis (1) and trichomonas (4) were treated with appropriate
antibiotics (Table 1). In addition, blood and semen samples were
obtained from twelve HIV-1-negative men without STIs from
North Carolina and from 6 men from Malawi to serve as a control
for the cytokine and chemokines analyses.
We used viral RNA extracted from blood plasma and seminal
plasma to generate cDNAs to use as a template in the single
genome amplification (SGA) protocol of the viral env gene [34–36].
The use of viral RNA allows for the examination of contempo-
raneously replicating virus. A mean of 27 amplicons were analyzed
per sample, with a range of 15 to 34 in the blood and 14 to 44
amplicons in the seminal plasma. Sampling this number of
genomes provides a 95% chance to detect a subpopulation in the
range of 10–15%, and provides reasonable power to estimate the
relative proportions of the major variants in the population [35].
The sequence of the entire env gene was determined for each
amplicon. The use of SGA precludes PCR recombination as a
source of confusion about the relationship between the viral
genomes present in each sample [36].
Author Summary
The work described in this report is directed at how HIV-1
viral RNA populations differ between the blood plasma
and male genital tract in established infection. This site is
of special interest since it is the proximal source of most
transmissions of HIV-1. Thus, lessons learned about HIV-1
in the seminal tract are directly relevant to the mechanism
of HIV-1 transmission. We have used single genome
amplification to generate viral sequences from paired
blood and semen samples in men with chronic HIV-1
infection. When compared to viral populations in blood
plasma, we observe that virus in the seminal plasma can
be equilibrated, clonally-amplified, or compartmentalized.
We have also performed a characterization of the cytokine
and chemokine milieu in these two compartments. We
report a dramatic concentration of immune modulators in
the seminal plasma relative to the blood, and these likely
enhance the potential for viral replication in this compart-
ment by creating an environment where target cells are
kept in an activated state. These data define new and
distinct features of virus:host interactions and represent a
significant advance in our understanding of HIV-1 replica-
tion in the male genital tract.
Table 1. Patient cohort to analyze blood and semen viral populations in established infection.
ID
a Subtype Blood VL
b Semen VL
b CD4 Count
c Blood seq Semen seq Semen Amplification
d Semen Compartment
C007 C 4.9 3.6 190 29 23 Amp Equilibrated
C009 C 5.1 5.3 505 26 28 Amp Equilibrated
C011 C 5.4 4.4 67 30 28 No Amp Equilibrated
C012 C 5.4 6.7 863 26 20 Amp Equilibrated
C018 C 6.2 6.4 116 32 30 No Amp Compartmentalized
C019 C 5.7 5.8 599 31 44 Amp Equilibrated
C047 C 5.1 5.3 291 19 27 Amp Compartmentalized
C070 C 5.4 5.1 172 34 30 Amp Equilibrated
C083 C 4.8 5.4 423 18 26 No Amp Compartmentalized
C109 C 4.8 5.7 328 18 25 Amp Equilibrated
C111 C 5.0 5.9 210 17 27 No Amp Equilibrated
C113 C 4.6 4.6 279 29 28 Amp Compartmentalized
700010333 B 4.2 4.7 501 23 33 Amp Equilibrated
700010501 B 4.3 4.5 514 18 14 Amp Equilibrated
701010380 B 5.1 3.6 129 18 15 Amp Compartmentalized
700011145 B 4.7 4.2 356 15 20 Amp Equilibrated
aC011 had syphilis without urethritis; C070, C083, C109, and C113 had asymptomatic trichomonas infection without urethritis.
bLog10 of HIV-1 viral RNA load (copies/ml).
cNumber of CD4
+ T lymphocytes/mm
3.
dPresence or absence of clonal outgrowth or amplification in seminal plasma.
doi:10.1371/journal.ppat.1001053.t001
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blood and semen
Figure 1 depicts the phylogenetic analysis of viral sequences in
the blood and semen for subjects C011 and C111. There was a
diverse population in the blood and this diversity was fully
represented in the semen. Furthermore, the complexity of the
sequences in the blood, where no two sequences were identical,
was also represented in the semen. We conclude that in these
subjects there was no compartmentalization in the seminal tract.
If there were local replication of virus in the seminal tract of
these subjects it must have represented the full complexity of the
virus in the blood. Alternatively, this virus did not replicate in
the seminal tract but rather was imported from the blood.
In either scenario, the viral populations in the blood and
semen were essentially identical, representing well-equilibrated
populations.
Detection of clonal amplification in the seminal
compartment
A different phylogenetic pattern was detected in subjects C007,
C009, C012, C019, C070, and C109 (Fig. 2 and Fig. S1). Similar
to the subjects where blood and semen populations were well-
equilibrated, these subjects had viral populations in the semen that
represented the full diversity of the virus in the blood. In addition,
the blood populations were highly complex and consistent with a
diverse viral population, with no sampling of identical blood
sequences with the exception of patient C109. However, there was
an additional feature of the viral populations in the semen of these
subjects that distinguished them from the virus in the blood. In
these subjects sampling of the viral population in semen resulted in
examples where identical or nearly identical sequences were
observed (Fig. 2, Fig. S1, Fig. S3, and Fig. S4-S15). Patient C109
had a clade of identical/nearly identical sequences that comprised
nearly 75% of the entire semen viral population. Similarly, patient
C009 had three duplicated viral variants that each comprised
,10% of the semen population, indicating a broad range in the
amount of sequence duplication that can exist within semen. We
term this phenomenon clonal amplification, and because of the
nature of the SGA strategy, this cannot be the result of PCR
resampling since each amplicon was generated from a single
template.
Autonomous replication in the seminal compartment
results in compartmentalization
In four of the 12 subjects with subtype C HIV-1 (C047, C083,
C018, and C113), a third relationship between the viral
populations in the blood and semen was seen. For these subjects
there was a deep branch point with high bootstrap support in the
phylogenetic tree separating sequences found in the blood from
sequences found in the semen (Fig. 3 and Supplemental Fig. S2).
In addition to visual inspection of the phylogenetic trees to
identify semen clades with long branch lengths with high
bootstrap support, the presence of compartmentalized sequences
was confirmed with the Slatkin-Maddison statistical [37] and
correlation coefficient tests [38] available through Hypothesis
Figure 1. Neighbor-joining tree of SGA-derived env amplicons for two patients with HIV-1 subtype C demonstrating equilibration
between blood and semen. Blood SGA-env sequences (red circles) and semen SGA-env sequences (blue triangles). Bootstrap values $70 are
shown. Genetic distance is indicated at the bottom of the figure, and represents the number of nucleotide substitutions per site. An outgroup was
included to root the tree but is not shown.
doi:10.1371/journal.ppat.1001053.g001
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PLoS Pathogens | www.plospathogens.org 3 August 2010 | Volume 6 | Issue 8 | e1001053Figure 2. Neighbor-joining tree of SGA-derived env amplicons for three patients with HIV-1 subtype C demonstrating clonal
amplification of identical or nearly identical sequences within semen. Blood SGA-env sequences (red circles) and semen SGA-env sequences
(blue triangles). Vertical blue bars highlight clonal amplification of specific variants. Bootstrap values $70 are shown. An outgroup was included to
root the tree but is not shown.
doi:10.1371/journal.ppat.1001053.g002
Figure 3. Neighbor-joining tree of SGA-derived env amplicons for two patients with HIV-1 subtype C demonstrating
compartmentalization between blood and semen. Blood SGA-env sequences (red circles) and semen SGA-env sequences (blue triangles).
Ovals highlight clades of compartmentalized sequences in the semen or blood. Vertical blue bars highlight clonal amplification of specific variants.
Bootstrap values $70 are shown. An outgroup was included to root the tree but is not shown.
doi:10.1371/journal.ppat.1001053.g003
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revealed that there is no gold standard from the variety of
statistical measures available for detecting compartmentalization;
therefore, multiple tests are recommended to determine the
existence of compartmentalization [40]. Compartmentalization
tests were performed with all viral sequences, and after removal
of duplicated sequences since amplified variants in the semen can
increase both the frequency of compartmentalization calls and
the statistical support for those calls (Supplemental Table S2).
Thus, compartmentalization of these viral populations was
observed in subjects C047, C083, C018, and C113 and indicates
an autonomously replicating subpopulation in the seminal tract
that followed a distinct evolutionary pathway. As a result of this
compartmentalized subpopulation, the virus in the semen was
genetically distinct from the virus in the blood. Two subjects
(C083 and C018) had compartmentalization of semen-derived
sequences without clonal amplification (Fig. 3 and Fig. S2). In
addition, two subjects (C047 and C113) had both clonal
amplification and compartmentalization of semen-derived se-
quences (Fig. 3, Fig. S2, Fig. S8, and Fig. S11). Similar to the
previous subjects with semen clonal amplification (with the
exception of C109 as previously mentioned), there were no
duplicated blood sequences. Thus, these data indicate that the
male genital tract is capable of supporting complex viral
populations, and that compartmentalization and amplification
can occur independently.
Equilibration, amplification, and compartmentalization
are characteristics of HIV-1 blood and semen populations
in different clades
In addition to the 12 men with HIV-1 subtype C infection, we
analyzed blood and semen plasma viral RNA populations from 4
men with subtype B infection (Fig. 4, Fig. S3, Fig. S12-15). Each of
the four had identical sequences (clonal amplification) in the
seminal plasma that ranged from ,10% to one-third of the semen
viral population. In contrast, none of the patients had identical
sequences in the blood plasma. In addition, three of the men had
equilibrated blood and seminal plasma sequences: 700010333,
700010501, and 700011145; whereas, one of the 4 subtype B
infected men (700010380) had significant compartmentalization of
semen-derived sequences. Thus, clonal amplification and com-
partmentalization within the seminal plasma is a common feature
of HIV-1 of different subtypes.
Evolutionary history of viral env gene sequences in
semen
We carried out an analysis for each subject using Bayesian
Evolutionary Analysis by Sampling Trees (BEAST) [41] to
estimate the time to most recent common ancestor (TMRCA) of
the amplified variants, and/or the TMRCA of compartmentalized
variants using maximum likelihood trees. Of note, the topologies
of the neighbor-joining and maximum likelihood trees were
Figure 4. Neighbor-joining tree of SGA-derived env amplicons for two patients with HIV-1 subtype B demonstrating amplification
and equilibration in the left panel, and amplification and compartmentalization of seminal sequences in the right panel. Blood SGA-
env sequences (red circles) and semen SGA-env sequences (blue triangles). The oval highlights clades of compartmentalized sequences in the semen.
Vertical blue bars highlight clonal amplification of specific variants. Bootstrap values $70 are shown. An outgroup was included to root the tree but is
not shown.
doi:10.1371/journal.ppat.1001053.g004
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phylogenetic methods produced concordant results in their
evolutionary models.
As a control to compare the BEAST estimates to known values
obtained from previously published sequence data sets, a separate
analysis was performed using a subset of published longitudinal env
sequences (Fig. S16) [42]. From this data set, we calculated the
time of divergence using C2-V5 env sequences obtained from
longitudinal plasma samples at 3, 29, 42, 58, 70, and 100 months
post-seroconversion; BEAST estimates of 10, 34, 49, 147, 144, and
204 months, respectively, were observed with a high coefficient of
determination (R
2=0.9155). Thus, in the setting of chronic HIV-1
infection, the observed BEAST estimates were similar to the
expected values for periods up to several years, but there is a trend
to overestimate time periods greater than four years by
approximately two-fold.
Next, we determined the TMRCA of amplified and/or
compartmentalized variants within seminal plasma. The TMRCA
for the oligoclonal amplifications within the seminal compartment
ranged from 1 to 375 days, with a mean of 57 days, indicating
recent divergence. In contrast to the short evolutionary times
observed with the semen variants displaying oligoclonal amplifi-
cation, the subjects with significant semen compartmentalization
had divergence estimates from 1.5 to 9.7 years, with a mean of 5.2
years. If clonally-amplified sequences were used only once, there
was negligible effect on the TMRCA of the entire tree, or the
TMRCA of amplified or compartmentalized variants (data not
shown). Thus, the TMRCA of the clonally amplified variants
tends to be relatively short in contrast to compartmentalized
variants, which represent more distant divergence. However, we
do not know if the rate of evolution in the semen is comparable to
the blood adding additional uncertainty to the accuracy of the
absolute values generated with the BEAST analysis.
To determine if populations were evolving randomly under
neutral evolution, a Tajima’s neutrality test was performed using
DnaSP [43]. Fifteen of the 16 patients showed no evidence of
selection (P values .0.10); however, C019 had a Tajima’s D of -
2.1 (P value ,0.05) implying either population size expansion, or
positive selection. Thus, a coalescent model of viral evolution as
assumed by BEAST remains valid for the majority of patients. In
the case of C019, the violation of a coalescent model was most
likely due to the blood compartment (Tajima’s D of -1.82, P value
,0.05) vs. the semen compartment (Tajima’s D of -1.60, P value
.0.05). Taken together, these data suggest that BEAST is a robust
tool to compare the TMRCA of amplified and compartmentalized
variants for the majority of the patients that were analyzed.
Enrichment of cytokines and chemokines in semen
To determine if the seminal plasma has a distinct immunologic
profile relative to blood plasma, we measured the levels of nineteen
cytokines and chemokines in the paired blood and semen samples
from 12 of the men with chronic HIV-1 subtype C infection. As a
control, we measured cytokines and chemokines from paired blood
and semen samples in 12 uninfected men from the US and 6
uninfected men from Malawi without STIs. There were two
features of the patterns of cytokines and chemokines (Fig. 5) that
are noteworthy. First, a subset of cytokines and chemokines (IL-5,
IL-7, IL-8, MIG, IP-10, and MCP-1) were concentrated in the
semen of uninfected men with median levels that were 5 to
approximately 1000 fold greater than in the blood; none of the
remaining cytokines or chemokines was as high as five-fold
concentrated in the semen (Fig. 5). Second, for seven of the
cytokines and chemokines (IL-1b, IL-4, IL6, IL-7, IL-8, GM-CSF,
and MCP-1) there was a significant increase in the semen:blood
ratio of HIV-infected subjects compared to the uninfected subjects;
conversely, MIG was significantly decreased in the infected
subjects. Although our small sample size prevented a robust
analysis, there were no cytokine correlates with amplification or
compartmentalization of HIV-1 sequences in the semen. More-
over, there were no correlates with cytokine levels, and HIV-1
viral loads, amplification, compartmentalization, or the presence
of asymptomatic STIs that were detected in five of the HIV-
infected men (data not shown, although the small sample size and
the intersubject variability precludes an assessment beyond more
general trends).
Discussion
The seminal compartment is the source of the transmitted virus
in a majority of the transmission events for HIV-1. Thus, an
understanding of the biology of HIV-1 in the seminal tract is
integral to understanding the biology of transmission, and a
comparison of blood and seminal sequences is critical to increase
our knowledge of viral dynamics. We have used viral sequence
populations to examine the dynamic relationship between virus
and host in the seminal tract, and identify multiple mechanisms by
which HIV-1 populations exist in the male genital tract. A
significant limitation of this study is that it is cross-sectional,
involving a single time point. Another limitation of the current
work is that there are no proviral sequences from semen cells to
define the source of the amplified or compartmentalized variants.
Previous work has identified paired blood and semen samples
where the viral populations were discordant. In some cases this
involved a comparison of viral RNA in blood plasma and seminal
plasma, or a comparison of the sequences in viral DNA in blood
cells and seminal cells [21–26,28,29,32]. While these studies
clearly established the potential for the virus to become
compartmentalized, in most cases there were two potential
limitations intrinsic to the experimental approach: the possibility
of recombination of viral sequences during PCR which would
introduce artifacts into the phylogenetic analysis, and the analysis
of a fairly small number of viral genomes in each population
precluding a comparison of the population structure. As a result
the phenomenon of compartmentalization has been described as a
dichotomous state, i.e. the presence or absence of compartmen-
talized viral populations. However, in subjects where there is
equilibration in the seminal tract over the entire range of
complexity in the blood compartment, virus in the semen is most
easily explained by the direct import of virus into the seminal
plasma from blood, perhaps with no local replication of this
population.
The enrichment of cytokines and chemokines in the seminal
tract (Fig. 5) likely contributes to an environment that is supportive
of HIV-1 replication. Our data, as well as others [44,45], show
that in the absence of HIV-1 infection several cytokines and
chemokines are enriched, suggesting that the seminal tract
maintains a constitutive state of innate immune activation. This
state is exacerbated with HIV-1 infection where the concentration
of a broader array of cytokines and chemokines indicates both
innate and adaptive responses shaping the environment [46].
Thus, target CD4+ T cells and macrophages are likely to be in an
activated state in this environment, enhancing their ability to
support viral replication.
In several subjects (C109 and 701010380) there is some
evidence for clonal amplification of sequences in the blood, with
this being more pronounced in C109. However, we do not know if
the mechanism causing selective outgrowth in the blood is the
same as that in the seminal tract, and in these subjects it is rare in
HIV-1 Populations In Semen
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semen in 12 of 16 men. The detection of clonal amplification
within the seminal compartment raises several important ques-
tions. First, does amplification represent an initial stage of
immunodeficiency? We have detected an example of clonal
amplification during primary infection (data not shown) suggesting
clonal amplification can occur at any stage of infection. Given that
clonal amplification was detected in equilibrated and compart-
mentalized populations, this also suggests that clonal amplification
is not determined by the overall state of immunodeficiency.
Second, what is the cellular source where this amplification
occurs? At one extreme clonally amplified sequences could be the
product of a single cell. This seems unlikely since the seminal tract
can support very complex populations in the compartmentalized
state consistent with many available target cells, and some of the
clonally amplified populations have some population structure
suggesting they are the result of multiple rounds of replication
(supported by the longer BEAST estimates of TMRCA for some of
these populations). The alternative is that clonal amplification
occurs in a population of cells that are not infected by diverse viral
genotypes. We suggest that either uninfected CD4+ T cells
concentrate in specific sites, or are seeded by a single cell that then
expands, until the focus of cells becomes infected with a single
virus that spreads through this isolated population until the target
cells are depleted. This would explain the self-limiting nature of
the clonal amplification and explain how several clonal amplifi-
cations can occur concurrently. Finally, this process could be at
work during compartmentalized virus replication, and thus
account for the clonal amplification process also appearing during
the replication of a complex compartmentalized population.
A corollary of the isolation of the clonally amplified population
is that the complex, compartmentalized population must be
sustained by a distinct mechanism. There is likely continued
import of virus from blood; however, the amount of locally
replicating virus must obscure detection of this imported
population. Based on these inferences we propose a model
Figure 5. Scatter plot of semen:blood analyte ratios of 17 cytokines and chemokines in HIV-1 infected (red circles) (n=12),
uninfected Malawi men (black circles) (n=6), and uninfected US men (black triangles) (n=12). Values that were below the lower limit of
detection were reported as the mid-point between the lower level of detection and zero. Semen:blood ratios were excluded if both compartments
were below the level of detection; thus, IL12 and IL13 were not included in the analysis. In the infected men, there were 6 to 11 subjects with
semen:blood analyte ratios for IL-1b, IL-2, IL-4, and IFN-g, whereas the remaining cytokines and chemokines had data from all 12 infected men. In
addition, after exclusion of values below the limit of detection in both semen and blood compartments, we quantified the semen:blood ratio for each
cytokine and chemokine from a range of 10 to 17 HIV-1 uninfected men. The dashed line illustrates an equivalent semen:blood analyte ratio.
Horizontal lines represent median values. Blue asterisks denote significant differences between infected and uninfected men, P value from Mann-
Whitney test ,0.003 (to correct for multiple comparisons). Boxed cytokines/chemokines have median semen:blood analyte ratios .5 in both HIV-1
infected and uninfected men.
doi:10.1371/journal.ppat.1001053.g005
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is that viral populations within blood and semen are turning over
similarly, and this is supported by a recent report in the literature
showing similar decay kinetics of HIV-1 populations in blood and
semen in men who initiate antiviral therapy [47]. In addition, our
model is distinct from the semen being a viral reservoir, which is
associated with reduced levels of viral replication [48]. We suggest
that virus in the semen is derived from multiple sources. First,
there is direct import of virus from the blood compartment,
potentially without replication in the seminal tract, accounting for
virus that is fully equilibrated between the blood and seminal tract
compartments. Second, there is infiltration of individual infected
CD4+ cells or virions into pockets of uninfected target cells that
generate local foci of infection in the seminal tract, giving rise to
clonal amplification of virus in this compartment. Third, ongoing
local immune activation provides an environment that can support
sustained, autonomous virus replication giving rise to compart-
mentalized virus. We estimate that this distinct population can
replicate independently for a significant period of time, although
lack of information about the rate of evolution in the compartment
precludes a detailed analysis of the age of the population.
An alternative interpretation of the appearance of compart-
mentalization is that there is delayed equilibration between blood
and the seminal tract. In this circumstance a change in the
population in the blood would not immediately be reflected in the
semen, giving the transient appearance of compartmentalization.
We do not favor this interpretation since the complexity of the
virus in the semen can be quite high giving TMRCA values of
months to years. However, the analysis of longitudinal samples in
subjects displaying compartmentalization will be required to
resolve this issue.
An important unanswered question is the site within the seminal
tract where virus undergoes independent replication. A relevant
observation in this regard is that vasectomy does not preclude the
presence of virus in semen [49,50], suggesting that production of
significant amounts of virus occurs outside of the testis, and
implicating the seminal vesicles and prostate. Moreover, distal
genitourinary sources other than the prostate have been implicated
as the major source of seminal HIV-1 in men without urethritis or
prostatitis [51]. In the setting of the blood compartment, disease
progression isassociated with higherlevelsofimmune cell activation
[52]. This may reflect an increasing trend to fail to control viral
replication but with a continued response to the presence of viral
antigen. We suggest a similar process may occur in the seminal tract
and perhaps in other peripheral sites of viral replication. Recent
literature reports the existence of clonal amplification of HIV-1
sequence in other compartments, including the CSF [53], breast
milk [54], and cervicovaginal lavage fluid [55]. Thus, an influx of
activated immune cells into areas where virus suppression is
incomplete could lead to sustained viral replication and a distinct
evolutionary pathway. In this regard, the presence of activated
immune cell infiltrates that have been observed in the seminal tract
of SIV-infected macaques [18] provides the likely sites where viral
replication could occur in the male genital tract.
Figure 6. Model demonstrating HIV-1 populations in the blood and male genital tract. Target cells traffic from blood to the male genital
tract. A semi-permeable barrier separates blood from the genital tract that allows passage of some free virus and uninfected and infected cells.
Equilibration of blood and seminal plasma sequences occurs through direct import of sequences from blood to semen. Clonal amplification results
from establishment of a local focus of infection of anatomically isolated uninfected cells in the genital tract. Compartmentalization occurs when
resident cell populations in the male genital tract become infected and there is persistent local replication. Gray circle, HIV-1 infected target cell.
White circle, HIV-1 uninfected target cell. Red circle, blood-derived virus. Blue circle, male genital tract-derived virus.
doi:10.1371/journal.ppat.1001053.g006
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clonal amplification and sustained replication, is to alter the
composition of the viral population in the semen relative to that in
the blood plasma. These differences can make blood a suboptimal
surrogate for the seminal compartment in assessing the relation-
ship of virus in the donor and recipient of a sexual transmission
event. Several studies have noted differences between the
transmitted virus and the virus in donor blood for subtypes A,
C, and D [56–60] but not subtype B [35,58], with differences in
either glycosylation patterns, variable loop lengths, or susceptibility
to neutralizing antibodies. It will be important to determine if the
distinctive features of virus in semen play a role in transmission
and/or in defining the nature of the transmitted virus.
Materials and Methods
Ethics statement and source of clinical samples
The patients infected with HIV-1 subtype C (n=12) were
enrolled through the Kamuzu Central Hospital in Lilongwe,
Malawi, between January and March, 1996 [33]. The protocol
was approved by the University of North Carolina Committee on
the Protection of Human Rights and the Malawi Health Sciences
Research Committee. All study participants gave written informed
consent and were offered a small payment for their participation.
The original study design was a prospective, sequential compar-
ison of two cohorts: HIV-1-infected men with urethritis who had
urethral discharge on physical exam and at least five white blood
cells per high-power field from a urethral swab, selected from the
STI clinic, and HIV-infected men without urethritis on physical
exam, selected from the dermatology clinic [33]. Blood and semen
samples used in the current study were collected from men
attending the dermatology clinic in Lilongwe, Malawi as described
previously [33]. For both the STI and dermatology clinics,
screening for gonorrhea, trichomonas, syphilis, and chlamydia was
performed. In addition, blood and semen samples were obtained
from participants with HIV-1 subtype B from the US (n=4) who
were enrolled through the CHAVI 001 clinical core, a multi-
center, prospective, observational cohort study of acute HIV-1
infection. IRB approval was awarded by each participating center
as well as the Division of AIDS. All study participants gave written
informed consent and were offered a small payment for their
participation. None of the subtype B infected participants had
urethritis on physical exam, and were negative for gonorrhea,
Chlamydia, syphilis, and trichomonas infection. Consistent with
established infection, all HIV-1 infected Malawi and US patients
were confirmed EIA and Western Blot positive at study
enrollment. Paired blood and seminal plasma samples from
HIV-1 uninfected males for cytokine/chemokine analyses were
obtained from the CHAVI 001 clinical core sites in the US (n=12)
and Africa (n=6).
Extraction of viral RNA and generation of amplicons
Cell-free blood plasma and seminal plasma were isolated and
frozen as previously described [1]. HIV-1 viral loads from blood
and seminal plasma from the Malawi men were determined by
quantitative nucleic-acid sequence-based-analysis (NASBA, Orga-
non-Teknika) [33], and by Roche Amplicor vRNA or Abbott
RealTime HIV-1 assays for the US men. Virus in the seminal
plasma was pelleted by centrifugation prior to RNA isolation to
remove the seminal plasma. The blood plasma or the resuspended
virus pellet from the seminal plasma was extracted to isolate viral
RNA using the QIAMP Viral RNA Mini Kit (Qiagen). For each
sample, approximately 10,000 viral RNA copies based on viral
load were extracted and eluted. cDNA synthesis was performed
using Superscript III Reverse Transcriptase (Invitrogen) with an
oligo-d(T) primer as previously described [34–36]. To confirm that
proviral DNA was not the source of SGA env-derived amplicons
from cell-free viral RNA, RT-minus blood (n=11) and seminal
(n=11) plasma samples were subjected to the SGA protocol; the
remaining samples had insufficient volume remaining for the RT-
minus control experiment. To preclude PCR recombination and
Taq-induced errors, single genome amplification (SGA) of the env
gene was performed using limiting dilution [34–36,61–63]. PCR
amplicons were bidirectionally sequenced. To ensure that
sequences arose from single DNA molecules, chromatograms with
double peaks, indicating amplification from more than one cDNA
template, were excluded. SGA-derived env amplicons with
frameshift mutations that resulted in premature stop codons were
also excluded. GenBank accession numbers are HM638460 to
HM639260.
Analysis of viral sequences
DNA sequence alignments were performed using clustal W
[64]. Phylogenetic trees were generated using a neighbor-joining
method (MEGA 4.0) [65]. Pairwise DNA distances were
computed using MEGA 4.0. Highlighter plots were generated to
visualize sequence differences (www.hiv.lanl.gov). A Tajima’s D
test for neutrality was performed for each patient using DnaSP
[43]. Compartmentalization of viral sequences was assessed by
using the Slatkin-Maddison test [37] and correlation coefficient
[38] available through HyPhy [39]. Gene flow was determined by
the number of migration events compared between semen and
blood after 10,000 permutations for the Slatkin-Maddison test.
Compartmentalization was defined when P values ,0.01 were
obtained with the Slatkin-Maddison test using all sequences except
the clonally-amplified sequences, of which only one was included,
and when concordant results were obtained with the correlation
coefficient test. More extreme P values were obtained when all of
the clonally amplified sequences were included (Supplemental
Table S2).
Detection of cytokines
Nineteen cytokines and chemokines were analyzed by luminex
from paired blood and seminal plasma from 12 HIV-1 infected
and uninfected subjects as previously described [66]. Concentra-
tions of IL-1b, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12
(p70), IL-13, IFN-g, TNF-a, and GM-CSF were measured using
LINCOplex Luminex high-sensitivity 13-plex kits (Millipore)
according to the manufacturer’s instructions. Concentrations of
MIP-1a, MIP-1b, RANTES, MCP-1, MIG, and IP-10 were
measured using custom standard sensitivity 6-plex kits (Bio-Rad)
according to the manufacturer’s instructions. Each sample was
assayed in duplicate, and cytokine standards supplied by the
manufacturer were run in parallel. Data were collected using the
Bio-plex Suspension Array Reader (Bio-Rad) and a regression
formula was used to calculate sample concentrations from
standard curves. Values that were below the lower limit of
detection were reported as the mid-point between the lower level
of detection and zero. Semen:blood analyte ratios were calculated
for each subject; however, data were excluded if both compart-
ments were below the level of detection. Saturated values were
reported as the upper limit of detection. Sensitivity values were
adjusted for samples where the volume was limited and had to be
diluted before the measurement. Statistical tests comparing analyte
levels were non-parametric Mann-Whitney-U test for two groups
(compartmentalization vs. equilibration), and Kruskal-Wallis test
for three groups (high amplification, low amplification, no
amplification). The non-parametric Mann-Whitney test was used
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and uninfected subjects.
Bayesian analysis
For each subject, blood and semen sequences were aligned
using ClustalW 2.0.7 [67]. Markov Chain Monte Carlo Simula-
tion (MCMC) using Bayesian inference was used to resolve a
phylogenetic tree with the highest posterior probability to estimate
the time of divergence from the most recent common ancestor
(MRCA) implemented in BEAST (Bayesian Evolutionary Analysis
by Sampling Trees v.1.4.8) [41]. Each independent run had a
chain length of 30,000,000 with a sample frequency of 1000. A
general time-reversible substitution model was used, with site
heterogeneity using a gamma distribution with a proportion of
invariant sites and sampling across four categories. Analyses were
performed using an HIV-1 generation time of 1.6 days [68]. Rate
heterogeneity across codon positions was unlinked, and the mean
fixed substitution rate was 2.16610
25 under a relaxed uncorre-
lated exponential molecular clock. A coalescent piecewise-constant
Bayesian Skyline model with ten groups was used as the tree prior.
The MCMC log output of each run was examined in Tracer 1.4 to
verify adequate chain mixing and estimated sample sizes of greater
than 200 for parameters of interest, and log and tree files with a
minimum of two independent runs were combined with a 10%
burn-in using LogCombiner 1.4.8. The target tree for each patient
was summarized using TreeAnnotater 1.4.8, and visualized in
FigTree1.1.2.
Supporting Information
Figure S1 Neighbor-joining tree of SGA-derived env amplicons
for three HIV-1 subtype C patients demonstrating equilibration
between blood and semen. Blood SGA-env sequences (red circles)
and semen SGA-env sequences (blue triangles). Vertical blue bars
highlight clonal amplification of specific variants. Bootstrap values
$70 are shown. An outgroup was included to root the tree but is
not shown.
Found at: doi:10.1371/journal.ppat.1001053.s001 (1.00 MB TIF)
Figure S2 Neighbor-joining tree of SGA-derived env amplicons
for two HIV-1 subtype C patients demonstrating compartmental-
ization of seminal sequences. Blood SGA-env sequences (red circles)
and semen SGA-env sequences (blue triangles). Ovals highlight
clades of compartmentalized sequences in the semen or blood.
Vertical blue bars highlight clonal amplification of specific
variants. Bootstrap values $70 are shown. An outgroup was
included to root the tree but is not shown.
Found at: doi:10.1371/journal.ppat.1001053.s002 (0.93 MB TIF)
Figure S3 Neighbor-joining tree of SGA-derived env amplicons
for two HIV-1 subtype B patients demonstrating clonal amplifi-
cation of seminal variants. Blood SGA-env sequences (red circles)
and semen SGA-env sequences (blue triangles). Vertical blue bars
highlight clonal amplification of specific variants. Bootstrap values
$70 are shown. An outgroup was included to root the tree but is
not shown.
Found at: doi:10.1371/journal.ppat.1001053.s003 (0.85 MB TIF)
Figure S4 Highlighter plot for patient C007 with clonal
amplification in the seminal tract. All blood (B) and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
seminal plasma. Each vertical tic represents a mismatch from the
master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s004 (3.81 MB TIF)
Figure S5 Highlighter plot for patient C009 with clonal
amplification in the seminal tract. All blood (B) and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
seminal plasma. Each vertical tic represents a mismatch from the
master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s005 (4.55 MB TIF)
Figure S6 Highlighter plot for patient C012 with clonal
amplification in the seminal tract. All blood (B) and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
seminal plasma. Each vertical tic represents a mismatch from the
master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s006 (3.88 MB TIF)
Figure S7 Highlighter plot for patient C019 with clonal
amplification in the seminal tract. All blood (B) and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
seminal plasma. Each vertical tic represents a mismatch from the
master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s007 (2.62 MB TIF)
Figure S8 Highlighter plot for patient C047 with clonal
amplification in the seminal tract. All blood and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
seminal plasma. Each vertical tic represents a mismatch from the
master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s008 (2.81 MB TIF)
Figure S9 Highlighter plot for patient C070 with clonal
amplification in the seminal tract. All blood (B) and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
seminal plasma. Each vertical tic represents a mismatch from the
master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s009 (3.99 MB TIF)
Figure S10 Highlighter plot for patient C109 with clonal
amplification in the seminal tract. All blood (B) and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
seminal plasma. Each vertical tic represents a mismatch from the
master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s010 (2.01 MB TIF)
Figure S11 Highlighter plot for patient C113 with clonal
amplification in the seminal tract. All blood (B) and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
seminal plasma. Each vertical tic represents a mismatch from the
master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s011 (3.26 MB TIF)
Figure S12 Highlighter plot for patient 700010333 with clonal
amplification in the seminal tract. All blood (B) and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
seminal plasma. Each vertical tic represents a mismatch from the
master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s012 (3.71 MB TIF)
Figure S13 Highlighter plot for patient 700010501 with clonal
amplification in the seminal tract. All blood (B) and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
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master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s013 (2.56 MB TIF)
Figure S14 Highlighter plot for patient 700011145 with clonal
amplification in the seminal tract. All blood (B) and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
seminal plasma. Each vertical tic represents a mismatch from the
master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s014 (2.27 MB TIF)
Figure S15 Highlighter plot for patient 701010380 with clonal
amplification in the seminal tract. All blood (B) and semen (S)
sequences are included. A representative amplified seminal variant
is used as the master to illustrate identical sequences within the
seminal plasma. Each vertical tic represents a mismatch from the
master sequence as outlined in the figure.
Found at: doi:10.1371/journal.ppat.1001053.s015 (4.05 MB TIF)
Figure S16 Relationship between documented time post-
seroconversion in years for patient 11 plasma (42) and BEAST
estimated time post-infection in years. Longitudinal samples were
analyzed using BEAST as outlined in the Methods.
Found at: doi:10.1371/journal.ppat.1001053.s016 (0.12 MB TIF)
Table S1 Semen and blood cytokine/chemokine analytes (pg/
ml) and ratios for HIV-1 infected and uninfected men.
Found at: doi:10.1371/journal.ppat.1001053.s017 (0.08 MB XLS)
Table S2 Results of Slatkin-Maddison test for compartmental-
ization using all blood and semen derived sequences, and with
each amplified variant only once.
Found at: doi:10.1371/journal.ppat.1001053.s018 (0.03 MB XLS)
Acknowledgments
P.B. is a Jenner Institute investigator.
Author Contributions
Conceived and designed the experiments: JAA LHP OD IH PK PB MSC
RS. Performed the experiments: LHP OD LA LK YT RS. Analyzed the
data: JAA LHP OD CBJ LK MH CDJ PB SF RS. Contributed reagents/
materials/analysis tools: JAA OD CBJ MH IH PK CDJ PB SF MSC.
Wrote the paper: JAA LHP RS. Performed the cytokine and chemokine
analyses and helped develop the model in Figure 5: OD PB. Performed all
viral RNA load assays and managed the sample repository: SF.
References
1. Pilcher CD, Joaki G, Hoffman IF, Martinson FE, Mapanje C, et al. (2007)
Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen
and blood during acute and chronic infection. AIDS 21: 1723–1730.
2. Pilcher CD, Price MA, Hoffman IF, Galvin S, Martinson FE, et al. (2004)
Frequent detection of acute primary HIV infection in men in Malawi. AIDS 18:
517–524.
3. Pilcher CD, Shugars DC, Fiscus SA, Miller WC, Menezes P, et al. (2001) HIV in
body fluids during primary HIV infection: implications for pathogenesis,
treatment and public health. AIDS 15: 837–845.
4. Tindall B, Evans L, Cunningham P, McQueen P, Hurren L, et al. (1992)
Identification of HIV-1 in semen following primary HIV-1 infection. AIDS 6:
949–952.
5. Pullium JK, Adams DR, Jackson E, Kim CN, Smith DK, et al. (2001) Pig-tailed
macaques infected with human immunodeficiency virus (HIV) type 2GB122 or
simian/HIV89.6p express virus in semen during primary infection: new model
for genital tract shedding and transmission. J Infect Dis 183: 1023–1030.
6. Ritola K, Pilcher CD, Fiscus SA, Hoffman NG, Nelson JA, et al. (2004) Multiple
V1/V2 env variants are frequently present during primary infection with human
immunodeficiency virus type 1. J Virol 78: 11208–11218.
7. Butler DM, Delport W, Kosakovsky Pond SL, Lakdawala MK, Cheng PM, et al.
(2010) The origins of sexually transmitted HIV among men who have sex with
men. Sci Transl Med 2: 18re1.
8. Fdeli US, Allen SA, Musonda R, Trask S, Hahn BH, et al. (2001) Virologic
and immunologic determinants of heterosexual transmission of human
immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 17: 901–
910.
9. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, et al.
(2001) Probability of HIV-1 transmission per coital act in monogamous,
heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357:
1149–1153.
10. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral
load and heterosexual transmission of human immunodeficiency virus type 1.
Rakai Project Study Group. N Engl J Med 342: 921–929.
11. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, et al. (2005) Rates
of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai,
Uganda. J Infect Dis 191: 1403–1409.
12. Butler DM, Smith DM, Cachay ER, Hightower GK, Nugent CT, et al. (2008)
Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen
as risk factors for HIV transmission among men who have sex with men. AIDS
22: 1667–1671.
13. Galvin SR, Cohen MS (2004) The role of sexually transmitted diseases in HIV
transmission. Nat Rev Microbiol 2: 33–42.
14. Serwadda D, Gray RH, Sewankambo NK, Wabwire-Mangen F, Chen MZ,
et al. (2003) Human immunodeficiency virus acquisition associated with genital
ulcer disease and herpes simplex virus type 2 infection: a nested case-control
study in Rakai, Uganda. J Infect Dis 188: 1492–1497.
15. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, et al. (2007) Semen-
derived amyloid fibrils drastically enhance HIV infection. Cell 131: 1059–
1071.
16. Gil T, Castilla JA, Hortas ML, Molina J, Redondo M, et al. (1995) CD4+ cells in
human ejaculates. Hum Reprod 10: 2923–2927.
17. Wolff H, Anderson DJ (1988) Male genital tract inflammation associated with
increased numbers of potential human immunodeficiency virus host cells in
semen. Andrologia 20: 404–410.
18. Le Tortorec A, Le Grand R, Denis H, Satie AP, Mannioui K, et al. (2008)
Infection of semen-producing organs by SIV during the acute and chronic stages
of the disease. PLoS One 3: e1792.
19. Miller CJ, Vogel P, Alexander NJ, Dandekar S, Hendrickx AG, et al. (1994)
Pathology and localization of simian immunodeficiency virus in the reproductive
tract of chronically infected male rhesus macaques. Lab Invest 70: 255–262.
20. Byrn RA, Kiessling AA (1998) Analysis of human immunodeficiency virus in
semen: indications of a genetically distinct virus reservoir. J Reprod Immunol 41:
161–176.
21. Eron JJ, Vernazza PL, Johnston DM, Seillier-Moiseiwitsch F, Alcorn TM, et al.
(1998) Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma:
implications for transmission. AIDS 12: F181–189.
22. Ghosn J, Chaix ML, Peytavin G, Rey E, Bresson JL, et al. (2004) Penetration of
enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of
HIV-1-infected men. AIDS 18: 1958–1961.
23. Kroodsma KL, Kozal MJ, Hamed KA, Winters MA, Merigan TC (1994)
Detection of drug resistance mutations in the human immunodeficiency virus
type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and
proviral DNA. J Infect Dis 170: 1292–1295.
24. Smith DM, Wong JK, Shao H, Hightower GK, Mai SH, et al. (2007) Long-term
persistence of transmitted HIV drug resistance in male genital tract secretions:
implications for secondary transmission. J Infect Dis 196: 356–360.
25. Ping LH, Cohen MS, Hoffman I, Vernazza P, Seillier-Moiseiwitsch F, et al.
(2000) Effects of genital tract inflammation on human immunodeficiency virus
type 1 V3 populations in blood and semen. J Virol 74: 8946–8952.
26. Zhu T, Wang N, Carr A, Nam DS, Moor-Jankowski R, et al. (1996) Genetic
characterization of human immunodeficiency virus type 1 in blood and genital
secretions: evidence for viral compartmentalization and selection during sexual
transmission. J Virol 70: 3098–3107.
27. Byrn RA, Zhang D, Eyre R, McGowan K, Kiessling AA (1997) HIV-1 in semen:
an isolated virus reservoir. Lancet 350: 1141.
28. Delwart EL, Mullins JI, Gupta P, Learn GH, Jr., Holodniy M, et al. (1998)
Human immunodeficiency virus type 1 populations in blood and semen. J Virol
72: 617–623.
29. Diem K, Nickle DC, Motoshige A, Fox A, Ross S, et al. (2008) Male genital tract
compartmentalization of human immunodeficiency virus type 1 (HIV). AIDS
Res Hum Retroviruses 24: 561–571.
30. Gupta P, Leroux C, Patterson BK, Kingsley L, Rinaldo C, et al. (2000) Human
immunodeficiency virus type 1 shedding pattern in semen correlates with the
compartmentalization of viral Quasi species between blood and semen. J Infect
Dis 182: 79–87.
31. Paranjpe S, Craigo J, Patterson B, Ding M, Barroso P, et al. (2002)
Subcompartmentalization of HIV-1 quasispecies between seminal cells and
seminal plasma indicates their origin in distinct genital tissues. AIDS Res Hum
Retroviruses 18: 1271–1280.
32. Pillai SK, Good B, Pond SK, Wong JK, Strain MC, et al. (2005) Semen-specific
genetic characteristics of human immunodeficiency virus type 1 env. J Virol 79:
1734–1742.
HIV-1 Populations In Semen
PLoS Pathogens | www.plospathogens.org 11 August 2010 | Volume 6 | Issue 8 | e100105333. Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, et al. (1997)
Reduction of concentration of HIV-1 in semen after treatment of urethritis:
implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi
Research Group. Lancet 349: 1868–1873.
34. Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, et al. (2009)
Quantitating the multiplicity of infection with human immunodeficiency virus
type 1 subtype C reveals a non-poisson distribution of transmitted variants.
J Virol 83: 3556–3567.
35. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. (2008)
Identification and characterization of transmitted and early founder virus
envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105:
7552–7557.
36. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, et al. (2008)
Deciphering human immunodeficiency virus type 1 transmission and early
envelope diversification by single-genome amplification and sequencing. J Virol
82: 3952–3970.
37. Slatkin M, Maddison WP (1989) A cladistic measure of gene flow inferred from
the phylogenies of alleles. Genetics 123: 603–613.
38. Critchlow DE, Li S, Nourijelyani K, Pearl DK (2000) Some statistical methods
for phylogenetic trees with application to HIV disease. Math Comput Model 32:
69–81.
39. Pond SL, Frost SD, Muse SV (2005) HyPhy: hypothesis testing using
phylogenies. Bioinformatics 21: 676–679.
40. Zarate S, Pond SL, Shapshak P, Frost SD (2007) Comparative study of methods
for detecting sequence compartmentalization in human immunodeficiency virus
type 1. J Virol 81: 6643–51.
41. Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by
sampling trees. BMC Evol Biol 7: 214.
42. Shankarappa R, Gupta P, Learn GH, Jr., Rodrigo AG, Rinaldo CR, Jr., et al.
(1998) Evolution of human immunodeficiency virus type 1 envelope sequences in
infected individuals with differing disease progression profiles. Virology 241:
251–259.
43. Librado P, Rozas J (2009) DnaSP v5: A software for comprehensive analysis of
DNA polymorphism data. Bioinformatics 25: 1451–1452.
44. Linge HM, Collin M, Giwercman A, Malm J, Bjartell A, et al. (2008) The
antibacterial chemokine MIG/CXCL9 is constitutively expressed in epithelial
cells of the male urogenital tract and is present in seminal plasma. J Interferon
Cytokine Res 28: 191–196.
45. Politch JA, Tucker L, Bowman FP, Anderson DJ (2007) Concentrations and
significance of cytokines and other immunologic factors in semen of healthy
fertile men. Hum Reprod 22: 2928–2935.
46. Berlier W, Bourlet T, Levy R, Lucht F, Pozzetto B, et al. (2006) Amount of
seminal IL-1beta positively correlates to HIV-1 load in the semen of infected
patients. J Clin Virol 36: 204–207.
47. Shen C, Ding M, Craigo JK, Tarwater P, Chatterjee R, et al. (2010) Genetic
characterization of HIV-1 from semen and blood from clade-C infected subjects
from India and effect of therapy in these body compartments. Virology doi:
10.1016/j.virol.2010.01.033.
48. Nickle DC, Jensen MA, Shriner D, Brodie SJ, Frenkel LM, et al. (2003)
Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and
compartments. J Virol 77: 5540–5546.
49. Anderson DJ, Politch JA, Martinez A, Van Voorhis BJ, Padian NS, et al. (1991)
White blood cells and HIV-1 in semen from vasectomised seropositive men.
Lancet 338: 573–574.
50. Krieger JN, Nirapathpongporn A, Chaiyaporn M, Peterson G, Nikolaeva I,
et al. (1998) Vasectomy and human immunodeficiency virus type 1 in semen.
J Urol 159: 820–825; discussion 825–826.
51. Coombs RW, Lockhart D, Ross SO, Deutsch L, Dragavon J, et al. (2006) Lower
genitourinary tract sources of seminal HIV. J Acquir Immune Defic Syndr 41:
430–438.
52. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, et al. (2004) Immune
activation set point during early HIV infection predicts subsequent CD4+ T-cell
changes independent of viral load. Blood 104: 942–947.
53. Schnell G, Price RW, Swanstrom R, Spudich S (2010) Compartmentalization
and clonal amplification of HIV-1 variants in the cerebrospinal fluid during
primary infection. J Virol 84: 2395–2407.
54. Permar SR, Kang HH, Wilks AB, Mach LV, Carville A, et al. (2010) Local
replication of simian immunodeficiency virus in the breast milk compartment of
chronically-infected, lactating rhesus monkeys. Retrovirology 7: 7.
55. Bull M, Learn G, Genowati I, McKernan J, Hitti J, et al. (2009)
Compartmentalization of HIV-1 within the female genital tract is due to
monotypic and low-diversity variants not distinct viral populations. PLoS One 4:
e7122.
56. Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, et al. (2004)
Envelope-constrained neutralization-sensitive HIV-1 after heterosexual trans-
mission. Science 303: 2019–2022.
57. Li M, Salazar-Gonzalez JF, Derdeyn CA, Morris L, Williamson C, et al. (2006)
Genetic and neutralization properties of subtype C human immunodeficiency
virus type 1 molecular env clones from acute and early heterosexually acquired
infections in Southern Africa. J Virol 80: 11776–11790.
58. Lynch RM, Shen T, Gnanakaran S, Derdeyn CA (2009) Appreciating HIV type
1 diversity: subtype differences in Env. AIDS Res Hum Retroviruses 25:
237–248.
59. Patel MB, Hoffman NG, Swanstrom R (2008) Subtype-specific conformational
differences within the V3 region of subtype B and subtype C human
immunodeficiency virus type 1 Env proteins. J Virol 82: 903–916.
60. Sagar M, Laeyendecker O, Lee S, Gamiel J, Wawer MJ, et al. (2009) Selection
of HIV variants with signature genotypic characteristics during heterosexual
transmission. J Infect Dis 199: 580–589.
61. Edmonson PF, Mullins JI (1992) Efficient amplification of HIV half-genomes
from tissue DNA. Nucleic Acids Res 20: 4933.
62. Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, et al. (2005) Multiple,
linked human immunodeficiency virus type 1 drug resistance mutations in
treatment-experienced patients are missed by standard genotype analysis. J Clin
Microbiol 43: 406–413.
63. Simmonds P, Balfe P, Ludlam CA, Bishop JO, Brown AJ (1990) Analysis of
sequence diversity in hypervariable regions of the external glycoprotein of
human immunodeficiency virus type 1. J Virol 64: 5840–5850.
64. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the
sensitivity of progressive multiple sequence alignment through sequence
weighting, position-specific gap penalties and weight matrix choice. Nucleic
Acids Res 22: 4673–4680.
65. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary
Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596–1599.
66. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, et al. (2009) Induction of
a striking systemic cytokine cascade prior to peak viremia in acute human
immunodeficiency virus type 1 infection, in contrast to more modest and delayed
responses in acute hepatitis B and C virus infections. J Virol 83: 3719–3733.
67. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007)
Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947–2948.
68. Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M, et al. (2003) A novel
antiviral intervention results in more accurate assessment of human immuno-
deficiency virus type 1 replication dynamics and T-cell decay in vivo. J Virol 77:
5037–5038.
HIV-1 Populations In Semen
PLoS Pathogens | www.plospathogens.org 12 August 2010 | Volume 6 | Issue 8 | e1001053